Clinical Trial Update: A Phase 0 of Neoadjuvant Lapatinib in Infiltrative Bladder Carcinoma Before Cystectomy [EARLY_Phase 1]

View source ↗

Summary

Phase 0 neoadjuvant trial of lapatinib for infiltrative bladder cancer before cystectomy; the study sponsored by University Hospital, Bordeaux has been terminat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Infiltrative Bladder Carcinoma

Drugs mentioned

• Lapatinib (Lapatinib)

Snippet

Sponsor: University Hospital, Bordeaux | Conditions: Bladder Carcinoma, Infiltrative Bladder Carcinoma | EARLY_Phase 1 | Status: TERMINATED